Sweden’s Affibody Inks Inmagene China R&D Pact
Affibody And Inmagene Will Focus On Auto-Immune Diseases
Swedish biotech Affibody hopes an R&D alliance with China-based Inmagene Biopharmaceuticals will speed development of its lead compound for auto-immune diseases.
